Lantheus Holdings, Inc. Finite-Lived Intangible Assets, Accumulated Amortization
Lantheus Holdings, Inc. (LNTH) had Finite-Lived Intangible Assets, Accumulated Amortization of $247.06 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $247.06M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $230.41M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $213.73M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $197.20M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2026-06-30 | $247.06M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $230.41M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $213.73M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $197.20M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $182.57M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $228.56M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $220.54M 10-K · filed 2026-02-26 |
| 2024-09-30 | $208.90M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $196.94M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $186.84M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $176.98M 10-K · filed 2025-02-26 |
| 2023-09-30 | $165.62M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $171.55M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $159.04M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $174.48M 10-K · filed 2024-02-22 |
| 2022-09-30 | $166.17M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $158.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $149.84M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $141.45M 10-K · filed 2023-02-23 |
| 2021-09-30 | $133.12M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $124.84M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $118.69M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $113.93M 10-K · filed 2022-02-24 |
| 2020-09-30 | $111.26M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $106.43M 10-Q · filed 2020-07-31 |
| 2019-12-31 | $105.22M 10-K · filed 2021-02-25 |
| 2018-12-31 | $109.89M 10-K · filed 2020-02-25 |
| 2017-12-31 | $143.66M 10-K · filed 2019-02-20 |
| 2016-12-31 | $140.13M 10-K · filed 2018-02-26 |
| 2016-09-30 | $138.93M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $139.37M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $138.03M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $136.56M 10-K · filed 2017-02-23 |
| 2015-09-30 | $137.93M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $137.05M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $134.50M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |